Bio-Works Technologies AB, a significant player in the biotech industry, has announced a strategic move to enhance transparency and communication with its stakeholders. Beginning with the fourth quarter of 2025, the company will issue business updates on a quarterly basis. These updates will include comprehensive details on net sales, order intake, and the status of the order book, providing a clearer picture of the company's financial health and operational progress.

The decision to implement quarterly updates is a proactive step towards fostering a more informed investor community. By reporting key metrics such as net sales and order intake promptly after the quarter's close, Bio-Works aims to offer a more immediate understanding of its business trajectory. For the fourth quarter of 2025, preliminary figures indicate net sales of 23.7 MSEK, a notable increase compared to previous quarters. The order intake for the same period stands at 25.6 MSEK, with an order book amounting to 32.5 MSEK as of December 31, 2025.

This initiative is expected to strengthen investor confidence by providing timely and relevant data, allowing for better-informed decision-making. As Bio-Works continues to support biotech companies globally in the purification of biomolecules, this move underscores its commitment to transparency and growth.

Given the positive trend in sales and order intake, potential investors might consider holding their positions in Bio-Works Technologies. The company's dedication to transparency and its strategic location in Uppsala, Sweden, bolster its reputation as a reliable partner in the biotech industry.